FRAMINGHAM, Mass., Nov. 23, 2011 /PRNewswire/ -- Dune Medical Devices, Inc. today announced that its CEO, Dan Levangie, will participate in the 23rd Annual Piper Jaffray Healthcare Conference and will present an overview of Dune Medical Devices at 3:10 PM on Wednesday, November 30, 2011.
The Piper Jaffray Healthcare Conference, being held on November 29 & 30, 2011 at the New York Palace Hotel, will feature 275 influential public and private companies in the biotechnology, specialty pharmaceuticals, drug discovery, medical technology, healthcare services, and medical diagnostics and devices sectors.
About Dune Medical Devices
Dune Medical Devices was founded in 2002 by Dr. Dan Hashimshony to realize the extraordinary medical potential of its proprietary cancer detection technology. Offering surgeons and radiologists the real time ability to identify cancerous tissues and react immediately, this technology holds the promise for a broad range of surgical and diagnostic applications. The MarginProbe System is Dune's first commercial product.
About the MarginProbe System
The MarginProbe System enables real time detection of cancer at or near the surface of excised tissue specimens during surgery for breast cancer. The simple and immediate assessment of the surgical margins allows surgeons to immediately excise additional tissue, potentially saving a second procedure.
Dune Medical Devices is a privately held company financed by Apax Partners. It has offices in the U.S., Israel and Switzerland. For more information, please visit www.dunemedical.com
Contact:
Michael Graffeo
Dune Medical Devices
111 Speen Street
Framingham, MA
508-620-2782
SOURCE Dune Medical Devices, Inc.